Cardiovascular dysfunction in cirrhosis: Pathophysiological evidence of a cirrhotic cardiomyopathy

Scandinavian Journal of Gastroenterology

Volumn 36, Issue 8, 2001, Pages 785-794

  Moller S ^a   Henriksen, J H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLIC CARDIOMYOPATHY; ARTERIAL PRESSURE; ARTERY DILATATION; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR DISEASE; EXERCISE; FLUID RETENTION; HEART FUNCTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART OUTPUT; HEART PRELOAD; HEART RATE; HEART VOLUME; HEMODYNAMICS; HUMAN; INOTROPISM; LIVER CIRRHOSIS; LUNG VASCULAR RESISTANCE; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QT INTERVAL; REVIEW; SODIUM RETENTION; SYMPATHETIC TONE;

EID: 0034960362     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655201750313289     Document Type: Review

References (138)

1. The cardiac output at rest in Laënnecs cirrhosis
2. Circulatory changes in chronic liver disease
3. Plasma volume in cirrhosis of the liver. Its relations to portal hypertension, ascites, and renal failure
4. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites
5. Systemic haemodynamic alterations in hepatic cirrhosis
6. Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension
7. Vasodilatation and hyperdynamic circulatory state in chronic liver disease
8. Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis
9. Evaluation of the baroreceptor-heart reflex by 24-hour intra-arterial blood pressure monitoring in humans
10. Arterial baroreceptor reflex: Its central and peripheral neural mechanisms
11. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis
12. Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension. Effect of propranolol
13. Reduced central blood volume in cirrhosis
14. Peripheral artery vasodilatation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
15. Vasodilatation associated with hepatocellular disease: Relation to functional organ failure
16. Peripheral arterial vasodilatation: Determinant of functional spectrum of cirrhosis
17. Arteriolar vasodilatation and the pathogenesis of the hyperdynamic circulation and renal sodium and water retention in cirrhosis
18. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis
19. Hyperdynamic circulation in cirrhosis: A role for nitric oxide?
20. Endothelins in chronic liver disease
21. Calcitonin gene-related peptide in hepatorenal syndrome
22. Increased adrenomedullin levels in cirrhosis: Relationship with hemodynamic abnormalities and vasoconstrictor systems
23. Natriuretic peptides: Are these new links in the hepatorenal connections?
24. Hyperdynamic circulation of cirrhotic rats with ascites: Role of endotoxin, tumour necrosis factor-alpha and nitric oxide
25. Systemic hemodynamic, forearm vascular, renal, and humoral responses to sustained cardiopulmonary baroreceptor deactivation in well-compensated cirrhosis
26. Hepatorenal disorders: Role of the sympathetic nervous system
27. Hepatorenal disorders. Role of the renin-angiotensin-aldosterone system
28. Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites
29. The role of central blood volume in the development of sodium retention in portal hypertensive rats
30. Hyperdynamic circulation of advanced cirrhosis: A re-appraisal based on posture-induced changes in hemodynamics
31. Impaired cardiovascular autonomic response to passive tilting in cirrhosis with ascites
32. Plasma endothelin-1 and -3 in cirrhosis: Relationship with systemic hemodynamics, renal function and neurohumoral systems
33. Diuretic treatment in decompensated cirrhosis and congestive heart failure: Effect of posture
34. The effect of posture on central blood volume in patients with preascitic cirrhosis on a sodium-restricted diet
35. Impairment of autonomic reflexes in cirrhosis
36. Natural history of autonomic neuropathy in chronic liver disease
37. Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites
38. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: Preliminary report of a prospective study
39. Effects of transjugular intrahepatic portasystemic shunt (TIPS) on splanchnic and systemic hemodynamics, and hepatic function in patients with portal hypertension: Preliminary results
40. Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients
41. Tumor necrosis factor alpha: A major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats
42. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats
43. Systemic and splanchnic hemodynamic changes in patients with hepatic schistosomiasis
44. Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension
45. Effect of anaemia on haemodynamics in patients with cirrhosis
46. Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients
47. Pathogenesis of sodium retention complicating cirrhosis: Is there room for diminished "effective" arterial blood volume?
48. Preclinical left ventricular abnormalities in alcoholics are independent of nutritional status, cirrhosis and cigarette smoking
49. Central blood volume in cirrhosi: Measurement with radionuclide angiography
50. Cardiac function in alcoholics with cirrhosis: Absence of overt cardiomyopathy: Myth or fact?
51. Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liver
52. Arterial underfilling does not cause sodium retention in cirrhosis
53. Atrial volume in cirrhosis: Relatioship to blood volume and plasma concentrations of atrial natriuretic factor
54. Ascites as a marker for the hyperdynamic heart of Laennec's cirrhosis
55. Pericardial effusion and left ventricular dysfunction associated with ascites secondary to hepatic cirrhosis
56. Ventricular function in cirrhosis and portasystemic shunt: A two-dimensional echocardiographic study
57. Relationship between cardiomyopathy and liver disease in chronic alcoholism
58. Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis
59. Left ventricular diastolic function in liver cirrhosis
60. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites
61. Decreased right heart blood volume determined by magnetic resonance imaging: Evidence of central underfilling in cirrhosis
62. Arterial vasodilation is not the cause of increased cardiac output in cirrhosis
63. Vasodilatory state of decompensated cirrhosis: Relation to hepatic dysfunction, ascites, and vasoactive substances
64. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis
65. Cardiac structure and function in experimental intra-hepatic portal hypertension
66. Total effective vascular compliance in patients with cirrhosis: A study of the response to acute blood volume expansion
67. Relationships between the severity of cirrhosis and haemodynamic values in patients with cirrhosis
68. Cardiac hemodynamics in alcoholic patients with chronic liver disease and a presystolic gallop
69. Hemodynamics after orthotopic liver transplantation: Study of associated factors and long-term effects
70. Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics
71. Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics in cirrhosis
72. The lung in patients with cirrhosis
73. Cardiovascular and pulmonary complications of liver disease
74. Distinctive clinical features of portopulmonary hypertension
75. Hepatopulmonary syndrome versus portopulmonary hypertension: Distinctions and dilemmas
76. The hepatopulmonary syndrome
77. Hepatopulmonary syndrome
78. Pulmonary hypertension: Diagnostics and therapeutics
79. Haemodynamic response to exercise in patients with alcoholic liver cirrhosis
80. Impaired left ventricular function in alcoholic cirrhosis with ascites
81. Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker
82. Cardiovascular effects of octreotide in patients with hepatic cirrhosis
83. Time profile of the haemodynamic effects of terlipressin in portal hypertension
84. Acute effect of low-dose theophylline on the circulatory disturbances of cirrhosis
85. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis
86. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: Effects on right ventricular function
87. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt
88. Transjugular intrahepatic portosystemic shunts. Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial
89. Transjugular intrahepatic portosystemic shunt: Short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis
90. Hyperdynamic circulation in cirrhosis: A historical perspective
91. Systemic haemodynamics in cirrhosis and portal hypertension with focus on vasoactive substances and prognosis
92. Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: Effects of posture
93. Negative influences of ascites on the cardiac function of cirrhotic patients
94. Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis
95. Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis
96. Analysis of impaired exercise capacity, in patients with cirrhosis
97. Arterial compliance in patients with cirrhosis. High stroke volume/pulse pressure ratio as an index of elevated arterial compliance
98. Cirrhotic cardiomyopathy: Getting to the heart of the matter
99. Limited cardiac preload reserve in conscious cirrhotic rats
100. Brain natriuretic peptide: Is it a predictor of cardiomyopathy in cirrhosis?
101. The sympathetic nervous system in liver disease
102. Elevated circulating cardiac troponin I in patients with cirrhosis
103. Impaired responsiveness to angiotensin-II in experimental cirrhosis: Role of nitric oxide
104. Impaired responsiveness to angiotensin II in experimental cirrhosis
105. Abnormal pressor response to vasopressin in patients with cirrhosis: Evidence for impaired buffering mechanisms
106. Cardiovascular hyporesponsiveness to norepinephrine, propranolol and nitroglycerin in portal-hypertensive and aged rats
107. Vascular NE responsiveness in portal hypertension: Role of portal pressure and portosystemic shunting
108. Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites
109. Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats
110. Cardiac excitation-contraction coupling in the portal hypertensive rat
111. Autonomic dysfunction in patients with nonalcoholic chronic liver disease
112. Autonomic regulation of heart rate and QT interval in nonalcoholic cirrhosis with ascites
113. Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease
114. Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis
115. The correction of autonomic dysfunction in cirrhosis by captopril
116. Cardiac muscarinic receptor function in rats with cirrhotic cardiomyopathy
117. Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis
118. Cardiopulmonary dysfunction in cirrhosis
119. Endogenous factors involved in the control of arterial tone in cirrhosis
120. Q-T prolongation and sudden cardiac death in patients with alcoholic liver disease
121. Q-T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors
122. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition
123. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats
124. Increased nitric oxide synthesis and inducible nitric oxide synthase expression in patients with alcoholic and non-alcoholic liver cirrhosis
125. Autonomic nervous system activity during infusion of L-arginine in patients with liver cirrhosis
126. Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related
127. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats
128. Left ventricular performance in alcoholic patients without chronic liver disease
129. The relation of alcoholic myopathy to cardiomyopathy
130. Circulating antibodies to cardiac protein-acetaldehyde adducts in alcoholic heart muscle disease
131. Circulating endothelin in cardiac operations: Influence of blood pressure and endotoxin
132. Systemic hypotension and renal failure in obstructive jaundice: Mechanistic and therapeutic aspects
133. Differential effects of jaundice and cirrhosis on beta-adrenoceptor signaling in three rat models of cirrhotic cardiomyopathy
134. Heart diseases affecting the liver and liver diseases affecting the heart
135. Cirrhotic cardiomyopathy and liver transplantation